New pharmacy tool is a resource for treating osteoporosis

January 31, 2024 Providence inScope Content Team

Author: Jenifer Smith, Pharm.D., BCPS, senior clinical pharmacy manager, Providence Health Plan

As a support tool for providers, the Providence regional pharmacy team is working to broadly share its Pathway to Treat guide, which offers best-evidence practices to optimize clinical outcomes. The Pathway to Treat tool is updated regularly with featured clinical topics and recommended pharmaceutical therapies.

In the latest update, the tool focuses on treating osteoporosis. The guide promotes adhering to clinical guidelines, improving quality, reducing variation and increasing efficient use of health care resources.

The updated Osteoporosis tool is now available. This useful, at-a-glance document includes:

A summary of guideline recommendations for bone mineral density (BMD) testing
An overview of disease state management recommendations
Guidance on selecting treatments, including:
- Dosing and administration
- Annual cost estimates
- Duration of therapy
Links to helpful resources

Electronic copies of the Pathway to Treat updates, including the Osteoporosis tool, are available through ProvLink under Resources > Literature.

For more information:

Call 503-574-7400

About the Author

The inScope content team focuses on bringing you the latest in clinical news from our team of world-class medical providers and physician leaders.
More Content by Providence inScope Content Team

Welcome to your journey for creating a healthier you

New pharmacy tool is a resource for treating osteoporosis

About the Author

Previous Article

Next Article

New pharmacy tool is a resource for treating osteoporosis

About the Author

Previous Article

Next Article

Most Recent Articles

The Gamma Knife Esprit stereotactic radiosurgery system moves beyond a fixed headframe to target the most challenging areas of the brain with exceptional accuracy.

Thousands upon thousands of cancer patients and family members at Providence have benefited from the life-changing work of Dr. Walter Urba. Learn about his remarkable career.

What is required to make clinical trials accessible to people in Hood River and other Columbia Gorge communities? Learn more about why it's important to expand access to studies and cancer care.

This prestigious award recognizes Dr. Fox’s extraordinary contributions to the field of immunotherapy and his lifelong dedication to advancing cancer research.

A joint study between Providence, Microsoft and the University of Washington detailing work to create a novel AI-powered pathology model that will lay the foundation to improve patient outcomes.

Years after the start of the pandemic, more than 200 patients continue to be cared for at Providence for ongoing symptoms that remain from contracting COVID-19. Learn how Providence continues helping.

A new investigator-initiated study for patients with metastatic melanoma and HNSCC aims to evaluate a galectin-3 inhibitor as a way to “remove the brakes” from the immune system.

The advent of MRI scanning of the brain and spinal cord was a giant leap forward in improving the ability to diagnose multiple sclerosis with greater sensitivity and reliability.

Growing the surgical oncology programs at Providence Cancer Institute is a testament to our commitment to providing research-focused, comprehensive services and improving outcomes for patients.

During winter months when the days are shorter and darker, both postpartum depression and baby blues may be more difficult.

A study led by Dr. Christopher Darus may offer hope to women with persistent endometrial cancer. Currently, the prognosis is poor for women with this form of cancer.

Providence researchers say comprehensive genomic profiling can be pivotal in identifying gene mutations in a patient and tailoring personalized treatment strategies.

Being able to assess the level of fibrosis and make appropriate referrals is important in the care of patients with Steatotic Liver Disease (formerly known as Fatty Liver).